Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Pediatric Rheumatology

Fig. 4

From: Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database

Fig. 4

Kaplan-Meier analysis according to the initiation and duration of steroid use. At the end of the 16-year cohort, the percentage of patients free of a second HSP was 94.7%, 88.1%, 84.0%, 55.3%, and 25.0% for patients with steroid initiation < 14 days and duration < 10 days, no steroid use, initiation ≥14 days and duration < 10 days, initiation ≥14 days and duration ≥10 days, initiation < 14 days and duration ;≥10 days, respectively

Back to article page